Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

• Sylvia Haas ,

  * E-mail: sylvia@sylviahaas.com

  Affiliation Formerly Klinikum rechts der Isar, Technical University of Munich, Munich, Germany

  ⨯
• Hugo ten Cate,

  Affiliation Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands

  ⨯
• Gabriele Accetta,

  Affiliation Thrombosis Research Institute, London, United Kingdom

  ⨯
• Pantep Angchaisuksiri,

  Affiliation Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

  ⨯
• Jean-Pierre Bassand,

  Affiliations Thrombosis Research Institute, London, United Kingdom, Department of Cardiology, EA 3920, University of Besançon, Besançon, France

  ⨯
• A. John Camm,

  Affiliation Division of Cardiovascular Sciences, St George’s University of London, London, United Kingdom

  ⨯
• Ramon Corbalan,

  Affiliation Department of Cardiology, Catholic University School of Medicine, Santiago, Chile

  ⨯
• Harald Darius,

  Affiliation Department of Cardiology, Vascular Medicine and Intensive Care Medicine, Vivantes Neukoelln Medical Centre, Berlin, Germany

  ⨯
• David A. Fitzmaurice,

  Affiliation Department of Primary Care Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

  ⨯
• Samuel Z. Goldhaber,

  Affiliation Division of Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States of America

  ⨯
• Shinya Goto,

  Affiliation Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan

  ⨯
• Barry Jacobson,

  Affiliation Department of Hematology and Molecular Medicine, Johannesburg Hospital, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Gloria Kayani,

  Affiliation Thrombosis Research Institute, London, United Kingdom

  ⨯
• Lorenzo G. Mantovani,

  Affiliation Center for Public Health Research (CESP), University of Milano-Bicocca, Milan, Italy

  ⨯
• Frank Misselwitz,

  Affiliation Bayer Pharma AG, Berlin, Germany

  ⨯
• Karen Pieper,

  Affiliation Duke Clinical Research Institute, Durham, NC, United States of America

  ⨯
• Sebastian M. Schellong,

  Affiliation Internal Medicine, Dresden-Friedrichstadt Hospital, Dresden, Germany

  ⨯
• Janina Stepinska,

  Affiliation Intensive Cardiac Therapy Clinic, Institute of Cardiology, Warsaw, Poland

  ⨯
• Alexander G. G. Turpie,

  Affiliation Department of Medicine, McMaster University, Hamilton, Canada

  ⨯
• Martin van Eickels,

  Affiliation Bayer Pharma AG, Berlin, Germany

  ⨯
• Ajay K. Kakkar,

  Affiliations Thrombosis Research Institute, London, United Kingdom, University College London, London, United Kingdom

  ⨯
•  [ ... ],
• for the GARFIELD-AF Investigators

  ¶A complete list of investigators is given in S1 File.

  ⨯
• [ view all ]
• [ view less ]